Read + Share
Rosenstock J. Response to Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide
1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial
Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin
Therapy: A Rando Diabetes Care 2021;44:e196-e197.
PMID: 34670790
|
 |
|
